Self-Assembly of\nHuman Fibrinogen into Microclot-Mimicking\nAntifibrinolytic Amyloid Fibrinogen Particles

Recent clinical studies have highlighted the presence\nof microclots\nin the form of amyloid fibrinogen particles (AFPs) in plasma samples\nfrom Long COVID patients. However, the clinical significance of these\nabnormal, nonfibrillar self-assembly aggregates of human fibrinogen\nremains debated due to the limited understanding of their structural\nand biological characteristics. In this study, we present a method\nfor generating mimetic microclots in vitro. Using this approach, the\nself-assembly process, structural organization of AFPs, and their\ninteractions with human plasma components were elucidated. The amyloid\ntransition of fibrinogen occurs under acidic conditions within a pH\nrange of 2.3–3.2. Well-dispersed amyloid oligomers of fibrinogen,\nranging in size from 1 to 5 μm, can be prepared at pH 2.8 after\n1 h of incubation. We tracked the dynamic self-assembly process at\nthe single-molecule level using high-speed atomic force microscopy\n(HS-AFM). The arrangement of amyloid oligomers manifests as well-ordered,\nstacked nanodomains with striped patterns, growing perpendicular to\nthe primary axis of the fibrinogen monomer. Upon transfer to physiological\nsolution conditions or human plasma, these amyloid oligomers further\naggregate into nonfibrillar structures at the micrometer scale, resembling\nthe microclots observed in the bloodstream of Long COVID patients.\nNotably, these AFPs exhibit characteristics consistent with microclots,\nincluding positive staining in thioflavin T (ThT) assays and resistance\nto fibrinolysis. Proteomic analysis suggests that AFPs interact with\nvarious components of human plasma and have an enhanced binding affinity\nwith complement C3 compared to native fibrinogen. This study enables\nthe in vitro preparation of mimetic microclots exhibiting amyloid\nfeatures. It is anticipated to facilitate further researches on the\nmechanisms, detection, and treatment of diseases associated with fibrinogen\namyloidogenesis.

Publication Details

Journal
Figshare
Published
2024-12-26
DOI
https://doi.org/10.1021/acsabm.4c01651.s001
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Self-Assembly of\nHuman Fibrinogen into Microclot-Mimicking\nAntifibrinolytic Amyloid Fibrinogen Particles

Figshare
Alzheimer's disease research and treatments
article

Self-Assembly of\nHuman Fibrinogen into Microclot-Mimicking\nAntifibrinolytic Amyloid Fibrinogen Particles

article en

Abstract

Recent clinical studies have highlighted the presence\nof microclots\nin the form of amyloid fibrinogen particles (AFPs) in plasma samples\nfrom Long COVID patients. However, the clinical significance of these\nabnormal, nonfibrillar self-assembly aggregates of human fibrinogen\nremains debated due to the limited understanding of their structural\nand biological characteristics. In this study, we present a method\nfor generating mimetic microclots in vitro. Using this approach, the\nself-assembly process, structural organization of AFPs, and their\ninteractions with human plasma components were elucidated. The amyloid\ntransition of fibrinogen occurs under acidic conditions within a pH\nrange of 2.3–3.2. Well-dispersed amyloid oligomers of fibrinogen,\nranging in size from 1 to 5 μm, can be prepared at pH 2.8 after\n1 h of incubation. We tracked the dynamic self-assembly process at\nthe single-molecule level using high-speed atomic force microscopy\n(HS-AFM). The arrangement of amyloid oligomers manifests as well-ordered,\nstacked nanodomains with striped patterns, growing perpendicular to\nthe primary axis of the fibrinogen monomer. Upon transfer to physiological\nsolution conditions or human plasma, these amyloid oligomers further\naggregate into nonfibrillar structures at the micrometer scale, resembling\nthe microclots observed in the bloodstream of Long COVID patients.\nNotably, these AFPs exhibit characteristics consistent with microclots,\nincluding positive staining in thioflavin T (ThT) assays and resistance\nto fibrinolysis. Proteomic analysis suggests that AFPs interact with\nvarious components of human plasma and have an enhanced binding affinity\nwith complement C3 compared to native fibrinogen. This study enables\nthe in vitro preparation of mimetic microclots exhibiting amyloid\nfeatures. It is anticipated to facilitate further researches on the\nmechanisms, detection, and treatment of diseases associated with fibrinogen\namyloidogenesis.

Figshare
Openalex Percentile: Top 56%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Self-Assembly of\nHuman Fibrinogen into Microclot-Mimicking\nAntifibrinolytic Amyloid Fibrinogen Particles · Figshare (2024) | TGRS Research Map | TGRS